Prediction of antibiotic resistance: time for a new preclinical paradigm?
Author(s) -
Morten Otto Alexander Sommer,
Christian Munck,
Rasmus ToftKehler,
Dan I. Andersson
Publication year - 2017
Publication title -
nature reviews microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 11.496
H-Index - 300
eISSN - 1740-1534
pISSN - 1740-1526
DOI - 10.1038/nrmicro.2017.75
Subject(s) - antibiotic resistance , biology , drug resistance , resistance (ecology) , antibiotics , drug development , intensive care medicine , risk analysis (engineering) , bioinformatics , drug , medicine , pharmacology , genetics , ecology
Predicting the future is difficult, especially for evolutionary processes that are influenced by numerous unknown factors. Still, this is what is required of drug developers when they assess the risk of resistance arising against a new antibiotic candidate during preclinical development. In this Opinion article, we argue that the traditional procedures that are used for the prediction of antibiotic resistance today could be markedly improved by including a broader analysis of bacterial fitness, infection dynamics, horizontal gene transfer and other factors. This will lead to more informed preclinical decisions for continuing or discontinuing the development of drug candidates.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom